Sean C. Semple
12Patents
10h-index
23Co-inventors
68Inventor score
Filing activity: May 14, 1998 → Aug 28, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6858225B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 185 | Expired |
| US6287591A | Charged therapeutic agents encapsulated in lipid particles containing four lipid components | Emerging Cross-Sectional Technologies | 125 | Expired |
| US6835395B1 | Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles | Emerging Cross-Sectional Technologies | 110 | Expired |
| US7341738B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 87 | Expired |
| US9139554B2 | Amino lipids and methods for the delivery of nucleic acids | Emerging Cross-Sectional Technologies | 72 | Active |
| US7811602B2 | Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof | Human Necessities | 64 | Active |
| US8021686B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 58 | Active |
| US7060828B2 | Liposomal camptothecins and uses thereof | Human Necessities | 28 | Expired |
| US10653780B2 | Amino lipids and methods for the delivery of nucleic acids | Emerging Cross-Sectional Technologies | 18 | Active |
| US7244448B2 | Liposomal antineoplastic drugs and uses thereof | Human Necessities | 13 | Expired |
| US7311924B2 | Compositions and methods for treating cancer | Human Necessities | 5 | Expired |
| US7452550B2 | Liposomal antineoplastic drugs and uses thereof | Human Necessities | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.